久久99国产这里只有精品/欧美黄片大全/男生晚上睡不着想看点害羞的/小可爱免费直播下载 - 久色网

首頁 ? CD19 knockout Nalm6-luciferase NTCC?人B細胞前體急性淋巴細胞白血病細胞株cell line-BioVector NTCC細胞保藏中心

CD19 knockout Nalm6-luciferase NTCC?人B細胞前體急性淋巴細胞白血病細胞株cell line-BioVector NTCC細胞保藏中心

  • 價  格:¥1998950
  • 貨  號:NTCC?CD19 knockout Nalm6-luciferase
  • 產  地:北京
點擊詢問我要采購
 竭誠為您服務!
BioVector NTCC典型培養物保藏中心
聯系人:Dr.Xu, Biovector NTCC Inc.

電話:400-800-2947 工作QQ:1843439339 (微信同號)

郵件:Biovector@163.com

手機:18901268599

地址:北京

已注冊
 

CD19 knockout Nalm6-luciferase NTCC?人B細胞前體急性淋巴細胞白血病細胞株human B-cell precursor acute lymphoblastic leukemia (ALL) cell line

BioVector NTCC質粒載體菌株細胞蛋白抗體基因保藏中心


The NTCC? CD19 knockout Nalm6-luciferase cell line is a valuable tool for research in immunology and oncology. Here's a breakdown of its key features and significance:

Key Features:

  • Nalm6 Origin: Derived from the Nalm6 cell line, a human B-cell precursor acute lymphoblastic leukemia (ALL) cell line.

  • CD19 Knockout: The CD19 gene, which encodes a protein essential for B-cell development and function, has been genetically removed using CRISPR/Cas9 technology.

  • Luciferase Expression: The cell line constitutively expresses firefly luciferase, allowing for non-invasive monitoring of cell growth and proliferation using bioluminescence imaging techniques.

Significance in Research:

  1. Studying CD19 Function: The CD19 knockout enables researchers to investigate the role of CD19 in B-cell development, signaling pathways, and immune responses.

  2. Cancer Research:

    • Modeling B-cell Malignancies: The cell line can serve as a model for B-cell malignancies, such as B-ALL, that express CD19.

    • Evaluating CD19-Targeted Therapies: The CD19 knockout can be used to assess the efficacy of CD19-targeted therapies, such as chimeric antigen receptor (CAR) T-cell therapies, which are revolutionizing cancer treatment.


  3. Drug Discovery: The cell line can be used to screen for new drugs that target B-cell malignancies or modulate B-cell function.

Applications:

  • Immunology Research: Studying B-cell development, differentiation, and function.

  • Oncology Research: Investigating B-cell malignancies, evaluating CD19-targeted therapies, and screening for new anticancer drugs.

  • Drug Discovery: Identifying and developing novel therapeutic agents for B-cell-related diseases.

Note:

  • The use of this cell line requires appropriate safety measures in the laboratory, as it involves working with genetically modified organisms.

  • The characteristics and behavior of the CD19 knockout Nalm6-luciferase cell line can be influenced by various factors, such as culture conditions and the presence of other cells or factors in the environment.

Image

Nalm6-Fluc-Puro/CD19-KO - Imanis Life Sciences | United States

Firefly Luciferase CD19 Knockout NALM6 Cell Line 82168

生產廠家Supplier:

BioVector NTCC質粒載體菌株細胞蛋白抗體基因保藏中心

E-mail:BioVector@163.com


http://www.biovector.net


您正在向 biovector.net  發送關于產品 CD19 knockout Nalm6-luciferase NTCC?人B細胞前體急性淋巴細胞白血病細胞株cell line-BioVector NTCC細胞保藏中心 的詢問

點擊“立即發送”后,我們將在1個工作日內與您取得聯系。